Gardner Lewis Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Gardner Lewis Asset Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,696,854	Closed	-$1.69M	–	79
2023 Q3	$1.69M	Buy	+1,696,854	New	+$1.3M	0.58%	42

Gardner Lewis Asset Management's CELL Position: Q4 2023 in Review

Gardner Lewis Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 1,696,854 shares — an estimated $1.69M sold.

Gardner Lewis Asset Management first reported a position in CELL in Q3 2023 and held it in 1 quarter. The position peaked at $1.69M in Q3 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Gardner Lewis Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Gardner Lewis Asset Management sold 1,696,854 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $1.69M.
Gardner Lewis Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Gardner Lewis Asset Management's PhenomeX Inc. Common Stock position peaked at $1.69M in Q3 2023.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.